Sanyuan Biotech (301206.SZ) dividend distribution for the first three quarters of 2024: 2.5 yuan per 10 shares, with the equity registration on January 9.

Sanyuan Biological (301206.SZ) announced the distribution of rights for the first three quarters of 2024, based on the company's current total share capital...

Zhitong FinanceJan 2 20:04

Express News | 220 stocks had financing purchases exceeding 100 million yuan, with ZTE receiving 2.168 billion yuan, ranking first.

BreakingsDec 26, 2024 09:19

Sanyuan Biological (301206.SZ): "The project for the annual production of 50,000 tons of erythritol and technology center has been completed and the remaining raised funds will be permanently used to supplement working capital."

On December 16, Gelonghui reported that Sanyuan Bio (301206.SZ) held the fourth meeting of the fifth Board of Directors and the fourth meeting of the fifth Supervisory Board on December 16, 2024, and reviewed and approved the proposal on the completion of some fundraising projects and the permanent supplementation of surplus funds into working capital. It was agreed to conclude the fundraising project for the initial public offering of Stocks "Annual production of 50,000 tons of erythritol and technology center project," and to allocate the surplus raised funds of 352.2712 million yuan (including payables for contract balances, warranty funds, and interest already received or receivable after deducting handling fees.

Gelonghui FinanceDec 16, 2024 17:45

Express News | Sanyuan Biotech: The USA has initiated anti-dumping and countervailing investigations against China's erythritol.

BreakingsDec 16, 2024 17:44

Sanyuan Biotech (301206.SZ): Luxin Capital has cumulatively reduced its Shareholding by 1.3021%.

On December 11, Gelonghui reported that Sanyuan Biological (301206.SZ) announced that the shareholder Loxin Capital, holding more than 5% of the shares, recently issued the "Notice of Shareholding Reduction Exceeding 1% and Equity Change Reaching 5%" and the "Simple Equity Change Report." From November 11, 2024, to December 10, 2024, Loxin Capital has cumulatively reduced its holdings by 2,627,650 shares, with the total reduced shareholding reaching 1.3021% of the current total share capital of the company (excluding 525,700 shares in the company's repurchase special securities account). Meanwhile, in conjunction with prior disclosures.

Gelonghui FinanceDec 11, 2024 18:40

San Yuan Biology (301206.SZ): Currently has the production capacity of 10,000 tons of allose.

Grain News, November 27th | San Yuan Biology (301206.SZ) stated on the investor interactive platform that the company currently has an annual production capacity of 10,000 tons of aloe vera sugar, which can better meet the diverse market demands.

Gelonghui FinanceNov 27, 2024 15:23